Your browser doesn't support javascript.
loading
Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study.
Astley, Joshua R; Biancardi, Alberto M; Hughes, Paul J C; Marshall, Helen; Collier, Guilhem J; Chan, Ho-Fung; Saunders, Laura C; Smith, Laurie J; Brook, Martin L; Thompson, Roger; Rowland-Jones, Sarah; Skeoch, Sarah; Bianchi, Stephen M; Hatton, Matthew Q; Rahman, Najib M; Ho, Ling-Pei; Brightling, Chris E; Wain, Louise V; Singapuri, Amisha; Evans, Rachael A; Moss, Alastair J; McCann, Gerry P; Neubauer, Stefan; Raman, Betty; Wild, Jim M; Tahir, Bilal A.
Afiliación
  • Astley JR; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Biancardi AM; Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK.
  • Hughes PJC; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Marshall H; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Collier GJ; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Chan HF; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Saunders LC; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Smith LJ; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Brook ML; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Thompson R; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Rowland-Jones S; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Skeoch S; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Bianchi SM; Royal National Hospital for Rheumatic Diseases, Royal United Hospital NHS Foundation Trust, Bath, UK.
  • Hatton MQ; Arthritis Research UK Centre for Epidemiology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.
  • Rahman NM; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Ho LP; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Brightling CE; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, UK.
  • Wain LV; MRC Human Immunology Unit, University of Oxford, Oxford, UK.
  • Singapuri A; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Evans RA; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Moss AJ; Department of Health sciences, University of Leicester, Leicester, UK.
  • McCann GP; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Neubauer S; University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK.
  • Raman B; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Wild JM; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Tahir BA; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
J Magn Reson Imaging ; 58(4): 1030-1044, 2023 10.
Article en En | MEDLINE | ID: mdl-36799341
ABSTRACT

BACKGROUND:

Recently, deep learning via convolutional neural networks (CNNs) has largely superseded conventional methods for proton (1 H)-MRI lung segmentation. However, previous deep learning studies have utilized single-center data and limited acquisition parameters.

PURPOSE:

Develop a generalizable CNN for lung segmentation in 1 H-MRI, robust to pathology, acquisition protocol, vendor, and center. STUDY TYPE Retrospective. POPULATION A total of 809 1 H-MRI scans from 258 participants with various pulmonary pathologies (median age (range) 57 (6-85); 42% females) and 31 healthy participants (median age (range) 34 (23-76); 34% females) that were split into training (593 scans (74%); 157 participants (55%)), testing (50 scans (6%); 50 participants (17%)) and external validation (164 scans (20%); 82 participants (28%)) sets. FIELD STRENGTH/SEQUENCE 1.5-T and 3-T/3D spoiled-gradient recalled and ultrashort echo-time 1 H-MRI. ASSESSMENT 2D and 3D CNNs, trained on single-center, multi-sequence data, and the conventional spatial fuzzy c-means (SFCM) method were compared to manually delineated expert segmentations. Each method was validated on external data originating from several centers. Dice similarity coefficient (DSC), average boundary Hausdorff distance (Average HD), and relative error (XOR) metrics to assess segmentation performance. STATISTICAL TESTS Kruskal-Wallis tests assessed significances of differences between acquisitions in the testing set. Friedman tests with post hoc multiple comparisons assessed differences between the 2D CNN, 3D CNN, and SFCM. Bland-Altman analyses assessed agreement with manually derived lung volumes. A P value of <0.05 was considered statistically significant.

RESULTS:

The 3D CNN significantly outperformed its 2D analog and SFCM, yielding a median (range) DSC of 0.961 (0.880-0.987), Average HD of 1.63 mm (0.65-5.45) and XOR of 0.079 (0.025-0.240) on the testing set and a DSC of 0.973 (0.866-0.987), Average HD of 1.11 mm (0.47-8.13) and XOR of 0.054 (0.026-0.255) on external validation data. DATA

CONCLUSION:

The 3D CNN generated accurate 1 H-MRI lung segmentations on a heterogenous dataset, demonstrating robustness to disease pathology, sequence, vendor, and center. EVIDENCE LEVEL 4. TECHNICAL EFFICACY Stage 1.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aprendizaje Profundo Tipo de estudio: Clinical_trials / Observational_studies Límite: Female / Humans / Male Idioma: En Revista: J Magn Reson Imaging Asunto de la revista: DIAGNOSTICO POR IMAGEM Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aprendizaje Profundo Tipo de estudio: Clinical_trials / Observational_studies Límite: Female / Humans / Male Idioma: En Revista: J Magn Reson Imaging Asunto de la revista: DIAGNOSTICO POR IMAGEM Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido